233 related articles for article (PubMed ID: 20502762)
1. Mediator release of neuropeptides after nasal provocation in perennial allergic rhinitis patients.
Gawlik R; DuBuske L
Rhinology; 2010 Jun; 48(2):206-10. PubMed ID: 20502762
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluticasone on neuropeptides in nasal lavage in persistent allergic rhinitis.
Schäper C; Gustavus B; Koch B; Ewert R; Felix SB; Kunkel G; Noga O; Gläser S
J Investig Allergol Clin Immunol; 2010; 20(3):214-21. PubMed ID: 20635787
[TBL] [Abstract][Full Text] [Related]
4. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
[TBL] [Abstract][Full Text] [Related]
5. Substance P is generated in vivo following nasal challenge of allergic individuals with bradykinin.
Baumgarten CR; O'Connor A; Dokic D; Schultz KD; Kunkel G
Clin Exp Allergy; 1997 Nov; 27(11):1322-7. PubMed ID: 9420137
[TBL] [Abstract][Full Text] [Related]
6. Does laser turbinectomy influence local allergic inflammation in the nose?
Jovanovic S; Dokic D
Rhinology; 1996 Mar; 34(1):46-9. PubMed ID: 8739871
[TBL] [Abstract][Full Text] [Related]
7. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
[TBL] [Abstract][Full Text] [Related]
8. Comparison of allergen-induced late inflammatory reactions in the nose and in the skin in house dust mite-allergic patients with or without asthma.
Lopuhaä CE; de Riemer MJ; Out TA; Sjamsoedin DH; Aalberse RC; Jansen HM; van der Zee JS
Int Arch Allergy Immunol; 2003 Apr; 130(4):266-74. PubMed ID: 12740527
[TBL] [Abstract][Full Text] [Related]
9. Nasal challenge with allergen leads to maxillary sinus inflammation.
Baroody FM; Mucha SM; Detineo M; Naclerio RM
J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
[TBL] [Abstract][Full Text] [Related]
10. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
11. Skin prick reaction and nasal provocation response in diagnosis of nasal allergy to the house dust mite.
Kanthawatana S; Maturim W; Fooanan S; Trakultivakorn M
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):427-30. PubMed ID: 9396976
[TBL] [Abstract][Full Text] [Related]
12. Nasal lavage fluid examination and rhinomanometry in the diagnostics of occupational airway allergy to laboratory animals.
Krakowiak A; Ruta U; Górski P; Kowalska S; Pałczyński C
Int J Occup Med Environ Health; 2003; 16(2):125-32. PubMed ID: 12921381
[TBL] [Abstract][Full Text] [Related]
13. Skin tests, T cell responses and self-reported symptoms in children with allergic rhinitis and asthma due to house dust mite allergy.
Moed H; van Wijk RG; de Jongste JC; van der Wouden JC
Clin Exp Allergy; 2009 Feb; 39(2):222-7. PubMed ID: 19032359
[TBL] [Abstract][Full Text] [Related]
14. Allergen provocation augments endotoxin-induced nasal inflammation in subjects with atopic asthma.
Eldridge MW; Peden DB
J Allergy Clin Immunol; 2000 Mar; 105(3):475-81. PubMed ID: 10719296
[TBL] [Abstract][Full Text] [Related]
15. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
Turner P; Dear J; Scadding G; Foreman JC
J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
[TBL] [Abstract][Full Text] [Related]
16. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R
Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor in allergen-induced nasal inflammation.
Choi GS; Park HJ; Hur GY; Choi SJ; Shin SY; Ye YM; Park HS
Clin Exp Allergy; 2009 May; 39(5):655-61. PubMed ID: 19236408
[TBL] [Abstract][Full Text] [Related]
18. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.
Corren J; Diaz-Sanchez D; Saxon A; Deniz Y; Reimann J; Sinclair D; Davancaze T; Adelman D
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):243-8. PubMed ID: 15478383
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor produced in nasal glands of perennial allergic rhinitis.
Matsune S; Ohori J; Sun D; Yoshifuku K; Fukuiwa T; Kurono Y
Am J Rhinol; 2008; 22(4):365-70. PubMed ID: 18702899
[TBL] [Abstract][Full Text] [Related]
20. Nasal endothelial interleukin-10 expression is negatively correlated with nasal symptoms after allergen provocation.
Muller B; de Groot EJ; Kortekaas IJ; Fokkens WJ; van Drunen CM
Allergy; 2009 May; 64(5):738-45. PubMed ID: 19383027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
